Quality of life metrics in LVAD patients after hemocompatibility-related adverse events.

Matthew P WeberJohn StulakSimon MaltaisFrancis D PaganiJennifer CowgerVakhtang Tchantchaleishvili

Published in: Artificial organs (2022)

The burden of HRAE following CF-LVAD implantation did not negatively impact the quality of life. However, the 6MWT did not increase in the post-HRAE period in all HRAE patients. Improvement of heart failure symptoms after CF-LVAD coupled with optimal management following the HRAE act to preserve the enhanced quality of life.

Keyphrases

end stage renal disease
heart failure
newly diagnosed
ejection fraction
chronic kidney disease
cystic fibrosis
prognostic factors
peritoneal dialysis
left ventricular